Literature DB >> 7388518

Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.

G Reach, M Thibonnier, C Chevillard, P Corvol, P Milliez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7388518      PMCID： PMC1601614          DOI： 10.1136/bmj.280.6227.1300-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.

Authors:  M Da Prada
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

2.  Hypertensive response to labetalol in phaeochromocytoma.

Authors:  R S Briggs; A J Birtwell; J E Pohl
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

Review 3.  A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.

Authors:  R T Brittain; G P Levy
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

4.  Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.

Authors:  E A Rosei; J J Brown; A F Lever; A S Robertson; J I Robertson; P M Trust
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335
  4 in total
  7 in total

Review 1.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Pheochromocytoma - update on disease management.

Authors:  Roland Därr; Jacques W M Lenders; Lorenz C Hofbauer; Bernd Naumann; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

3.  Successful Management of Phaeochromocytoma using Preoperative Oral Labetalol and Intraoperative Magnesium Sulphate: Report of four cases.

Authors:  S B Sanath Kumar; Rohit Date; Nicholas Woodhouse; Omayma El-Shafie; Karin Nollain
Journal:  Sultan Qaboos Univ Med J       Date:  2014-04-07

4.  Pheochromocytoma crisis presenting with cardiogenic shock.

Authors:  Y S Chatzizisis; A Ziakas; C Feloukidis; D Paramythiotis; S Hadjimiltiades; A Iliadis; G Basdanis; I Styliadis
Journal:  Herz       Date:  2013-03-14       Impact factor: 1.443

5.  Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.

Authors:  T Yamaguchi; C Irisawa; H Watanabe; S Kawamura; T Nakada
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

6.  Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.

Authors:  Henrique Vara Luiz; Mary Jane Tanchee; Maria G Pavlatou; Run Yu; Joan Nambuba; Katherine Wolf; Tamara Prodanov; Robert Wesley; Karen Adams; Tito Fojo; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-15       Impact factor: 3.478

Review 7.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.